Research & Development

Can Nature's Peptides Defeat Melanoma Drug Resistance?
Research & Development Can Nature's Peptides Defeat Melanoma Drug Resistance?

The fight against advanced melanoma, a particularly aggressive form of skin cancer, has long been hindered by the cancer's ability to develop resistance to conventional treatments. However, a groundbreaking study led by QUT researchers at Brisbane's Translational Research Institute (TRI) offers a

Factors Influencing Participation in COVID-19 Vaccine Trials
Research & Development Factors Influencing Participation in COVID-19 Vaccine Trials

The COVID-19 pandemic presented a global challenge, with governments and health institutions striving to contain the virus amid misinformation and rapid transmission. One pivotal approach was the development of various COVID-19 vaccine trials, employing adaptive methods to expedite recruitment

Can Russia's New mRNA Vaccine Revolutionize Cancer Treatment by 2025?
Research & Development Can Russia's New mRNA Vaccine Revolutionize Cancer Treatment by 2025?

The recent announcement by Russia regarding the development of a groundbreaking mRNA cancer vaccine represents a significant milestone in the global fight against cancer. Scheduled for free distribution in early 2025, this innovative vaccine has captured worldwide attention due to its potential to

Can Patient-Centered Design Transform Clinical Trial Spaces?
Research & Development Can Patient-Centered Design Transform Clinical Trial Spaces?

Clinical trials are essential for advancing medical research and developing new treatments. However, one of the significant challenges faced by clinical trials is patient enrollment. According to GlobalData, over half of clinical trial failures are due to enrollment problems. Patients often feel

Does 5-FU Fight Cancer by Targeting RNA Instead of DNA?
Research & Development Does 5-FU Fight Cancer by Targeting RNA Instead of DNA?

5-Fluorouracil (5-FU) has been a cornerstone in cancer treatment for decades, primarily believed to work by damaging DNA and preventing cancer cells from replicating. However, recent research suggests that 5-FU's primary mechanism of action may be through targeting RNA, particularly ribosomal RNA,

Can CAR T-Cell Therapy Offer Hope for Severe Lambert-Eaton Myasthenic Syndrome?
Research & Development Can CAR T-Cell Therapy Offer Hope for Severe Lambert-Eaton Myasthenic Syndrome?

Lambert-Eaton myasthenic syndrome (LEMS) is a rare and debilitating autoimmune disorder where the immune system mistakenly attacks the body's own tissues, specifically targeting voltage-gated calcium channels (VGCCs) on nerve cells. This disruption in nerve-muscle communication results in muscle

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later